Evaluation of anti-Toxoplasma effects of solid lipid nanoparticles carrying Cinnamon zeylanicum and Moringa oleifera oil extracts.
Cinnamon zeylanicum
Moringa oleifera
Toxoplasma gondii
Solid lipid nanoparticles
Journal
BMC complementary medicine and therapies
ISSN: 2662-7671
Titre abrégé: BMC Complement Med Ther
Pays: England
ID NLM: 101761232
Informations de publication
Date de publication:
24 Oct 2024
24 Oct 2024
Historique:
received:
20
04
2024
accepted:
08
10
2024
medline:
25
10
2024
pubmed:
25
10
2024
entrez:
25
10
2024
Statut:
epublish
Résumé
The fabrication of anti-Toxoplasma drugs with less side effects and desirable efficacy is one of the important research goals facing with toxoplasmosis. This study aimed to determine the anti-Toxoplasma effects of Cinnamon zeylanicum (CZ), Moringa oleifera (MO) oil encapsulated into solid lipid nanoparticles (SLNs). Vero cells were cultured with serial concentrations (1 mg/mL to 100 µg/mL) of CZ-SLNs and MO-SLNs in DMEM culture medium. The morphological, physical, and chemical features of nanoparticles were calculated. The cell viability assays and anti-T. gondii effects of CZ-SLNs and MO-SLNs were evaluated. The CC The particle sizes of MO-SLNs and CZ-SLNs were 411.5 and 365 nm, while PDI indices were 0.53 and 0.7, respectively. Transmission electron microscopy (TEM) showed that both MO-SLNs and CZ-SLNs were smoothed spherical nanoparticles with rounded edges. The cytotoxicity assay showed the CC The current results represented that the use of SLNs as a nano-carrier for M. oleifera and C. zeylanicum could kill T. gondii tachyzoites with low cytotoxicity, suggesting the effectiveness of these nano-emulsions along with the chemical agents in the treatment of Toxoplasma.
Sections du résumé
BACKGROUND
BACKGROUND
The fabrication of anti-Toxoplasma drugs with less side effects and desirable efficacy is one of the important research goals facing with toxoplasmosis. This study aimed to determine the anti-Toxoplasma effects of Cinnamon zeylanicum (CZ), Moringa oleifera (MO) oil encapsulated into solid lipid nanoparticles (SLNs).
METHODS
METHODS
Vero cells were cultured with serial concentrations (1 mg/mL to 100 µg/mL) of CZ-SLNs and MO-SLNs in DMEM culture medium. The morphological, physical, and chemical features of nanoparticles were calculated. The cell viability assays and anti-T. gondii effects of CZ-SLNs and MO-SLNs were evaluated. The CC
RESULTS
RESULTS
The particle sizes of MO-SLNs and CZ-SLNs were 411.5 and 365 nm, while PDI indices were 0.53 and 0.7, respectively. Transmission electron microscopy (TEM) showed that both MO-SLNs and CZ-SLNs were smoothed spherical nanoparticles with rounded edges. The cytotoxicity assay showed the CC
CONCLUSION
CONCLUSIONS
The current results represented that the use of SLNs as a nano-carrier for M. oleifera and C. zeylanicum could kill T. gondii tachyzoites with low cytotoxicity, suggesting the effectiveness of these nano-emulsions along with the chemical agents in the treatment of Toxoplasma.
Identifiants
pubmed: 39449016
doi: 10.1186/s12906-024-04677-x
pii: 10.1186/s12906-024-04677-x
doi:
Substances chimiques
Plant Extracts
0
Plant Oils
0
Lipid Nanoparticles
0
Antiprotozoal Agents
0
Liposomes
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
375Subventions
Organisme : Shahid Beheshti University of Medical Sciences
ID : 43007082
Informations de copyright
© 2024. The Author(s).
Références
Hill D, Dubey J. Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microb Infect. 2002;8(10):634–640.
Dunay IR, et al. Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice. Clin Microb Rev. 2018;31(4):e00057–17.
doi: 10.1128/CMR.00057-17
Dubey JP. The history of Toxoplasma gondii—the first 100 years. J Eukaryot Microbiol. 2008;55(6):467–475.
pubmed: 19120791
doi: 10.1111/j.1550-7408.2008.00345.x
Sharif M, et al. The efficacy of herbal medicines against Toxoplasma gondii during the last 3 decades: a systematic review. Can J Physiol Pharmacol. 2016;94(12):1237–1248.
pubmed: 27564395
doi: 10.1139/cjpp-2016-0039
Frénal K, et al. Gliding motility powers invasion and egress in Apicomplexa. Nat Rev Microbiol. 2017;15(11):645–660.
pubmed: 28867819
doi: 10.1038/nrmicro.2017.86
Rahimi MT, et al. Cats and Toxoplasma gondii: a systematic review and meta-analysis in Iran. J Vet Res. 2015;82(1):1–10.
Ben-Harari RR, Goodwin E, Casoy J. Adverse event profile of pyrimethamine-based therapy in toxoplasmosis: a systematic review. Drugs R&D. 2017;17:523–544.
pubmed: 28879584
pmcid: 5694419
doi: 10.1007/s40268-017-0206-8
Elazab ST, Soliman AF, Nishikawa Y. Effect of some plant extracts from Egyptian herbal plants against Toxoplasma gondii tachyzoites in vitro. J Vet Med Sci. 2021;83(1):100–107.
pubmed: 33268605
doi: 10.1292/jvms.20-0458
Al Nasr I, et al. Toxoplasmosis and anti-Toxoplasma effects of medicinal plant extracts-A mini-review. Asian Pac J Trop Med. 2016;9(8):730–734.
pubmed: 27569880
doi: 10.1016/j.apjtm.2016.06.012
Ferguson DJ, Toxoplasma gondii. 1908–2008, homage to nicolle, manceaux and splendore. Mem Inst Oswaldo Cruz. 2009;104:133–148.
pubmed: 19430635
doi: 10.1590/S0074-02762009000200003
Yatoo M, et al. Anti-inflammatory drugs and herbs with special emphasis on herbal medicines for countering inflammatory diseases and disorders-a review. Recent Pat Inflamm Allergy Drug Discov. 2018;12(1):39–58.
pubmed: 29336271
doi: 10.2174/1872213X12666180115153635
Gandhimathi R, Saravanakumar A, Aanandhi MV. Current herbal drugs trends: a review. Tamil Nadu, India: Thanuj International; 2022:383.
Wong Y, Ahmad-Mudzaqqir M, Wan-Nurdiyana W. Extraction of essential oil from cinnamon (Cinnamomum zeylanicum). Orient J Chem. 2014;30(1):37.
doi: 10.13005/ojc/300105
Paranagama P et al. A comparison of essential oil constituents of bark, leaf, root and fruit of cinnamon (Cinnamomum zeylanicum Blum) grown in Sri Lanka. J Natl Sci Found Sri Lanka. 2001;29(3–4).
Ranasinghe P, et al. Medicinal properties of ‘true’cinnamon (Cinnamomum zeylanicum): a systematic review. BMC Complement Alternat Med. 2013;13(1):1–10.
doi: 10.1186/1472-6882-13-275
Rao PV, Gan SH. Cinnamon: a multifaceted medicinal plant. J Evid Based Comp Altern Med. 2014;2014.
Gruenwald J, Freder J, Armbruester N. Cinnamon and health. Crit Rev Food Sci Nutr. 2010;50(9):822–834.
pubmed: 20924865
doi: 10.1080/10408390902773052
Alanazi AD, Almohammed HI. Therapeutic potential and safety of the Cinnamomum zeylanicum methanolic extract against chronic Toxoplasma gondii Infection in mice. Front Cell Infect Microbiol. 2022;12:900046.
doi: 10.3389/fcimb.2022.900046
Nemattalab M, et al. Formulation of Cinnamon (Cinnamomum verum) oil loaded solid lipid nanoparticles and evaluation of its antibacterial activity against multi-drug resistant Escherichia coli. BMC Complement Med Ther. 2022;22(1):289.
pubmed: 36352402
pmcid: 9647953
doi: 10.1186/s12906-022-03775-y
Abdull Razis AF, Ibrahim MD, Kntayya SB. Health benefits of Moringa oleifera. Asian Pac J Cancer Prev. 2014;15(20):8571–8576.
pubmed: 25374169
doi: 10.7314/APJCP.2014.15.20.8571
Gandji K, et al. Status and utilisation of Moringa oleifera Lam: a review. Afr Crop Sci J. 2018;26(1):137–156.
doi: 10.4314/acsj.v26i1.10
Abdel-Latif HM, et al. Benefits and applications of Moringa oleifera as a plant protein source in aquafeed: a review. Aquaculture. 2022;547:737369.
doi: 10.1016/j.aquaculture.2021.737369
Abd El-Hack ME et al. Pharmacological, nutritional and antimicrobial uses of Moringa oleifera Lam. Leaves in poultry nutrition: an updated knowledge. Poult Sci. 2022;102031.
Peixoto JRO, et al. In vitro antibacterial effect of aqueous and ethanolic Moringa leaf extracts. Asian Pac J Trop Med. 2011;4(3):201–204.
pubmed: 21771453
doi: 10.1016/S1995-7645(11)60069-2
Patel P, et al. Phytochemical analysis and antifungal activity of Moringa oleifera. Int J Pharm Sci Res. 2014;6(5):144–147.
Nishi L, et al. Moringa oleifera extract promotes apoptosis-like death in Toxoplasma gondii tachyzoites in vitro. Parasitol. 2021;148(12):1447–1457.
doi: 10.1017/S0031182021001086
Mohamed AA, Alotaibi BM. Essential oils of some medicinal plants and their biological activities: a mini review. Umm Al-Qura Univ Appl Sci. 2023;9(1):40–49.
doi: 10.1007/s43994-022-00018-1
Nemati S, et al. Formulation of Neem oil-loaded solid lipid nanoparticles and evaluation of its anti-Toxoplasma activity. BMC Complemen Med Ther. 2022;22(1):122.
doi: 10.1186/s12906-022-03607-z
Mamillapalli V. Nanoparticles for herbal extracts. Asian J Pharm (AJP). 2016;10(2).
Mukherjee S, Ray S, Thakur R. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J Pharm Sci. 2009;71(4):349.
pubmed: 20502539
pmcid: 2865805
doi: 10.4103/0250-474X.57282
Jacob S et al. Lipid nanoparticles as a Promising drug delivery carrier for topical ocular therapy-an overview on recent advances. Pharmaceutics. 2022;14(3).
Dhiman N et al. Lipid nanoparticles as carriers for bioactive delivery. Front Chem. 2021;9.
Uner M, Yener G. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int J Nanomed. 2007;2(3):289–300.
Khosravi M, et al. In vitro evaluation of mannosylated paromomycin-loaded solid lipid nanoparticles on acute toxoplasmosis. Front Cell Infect Microbiol. 2020;10:33.
pubmed: 32117807
pmcid: 7031658
doi: 10.3389/fcimb.2020.00033
Cheraghipour K, et al. Synthesis, characterization, and antiparasitic effects of zinc oxide nanoparticles-eugenol nanosuspension against Toxoplasma gondii infection. Heliyon. 2023;9(8):e19295.
pubmed: 37654466
pmcid: 10465954
doi: 10.1016/j.heliyon.2023.e19295
Katlama C, et al. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS. Clin Infect Dis. 1996;22(2):268–275.
pubmed: 8838183
doi: 10.1093/clinids/22.2.268
Cheraghipour K, et al. The experimental role of medicinal plants in treatment of Toxoplasma gondii infection: a systematic review. Act Parasitol. 2021;66(2):303–328.
doi: 10.1007/s11686-020-00300-4
Torre D, et al. Randomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Antimicrob Agents Chemother. 1998;42(6):1346–1349.
pubmed: 9624473
pmcid: 105601
doi: 10.1128/AAC.42.6.1346
Doliwa C, et al. Identification of differentially expressed proteins in sulfadiazine resistant and sensitive strains of Toxoplasma gondii using difference-gel electrophoresis (DIGE). Int J Parasitol: Drugs Drug Resist. 2013;3:35–44.
pubmed: 24533291
Benoit-Vical F, et al. Anti-Toxoplasma activity of vegetal extracts used in west African traditional medicine. Parasite. 2000;7(1):3–7.
pubmed: 10743641
doi: 10.1051/parasite/2000071003
Sofowora A, Ogunbodede E, Onayade A. The role and place of medicinal plants in the strategies for disease prevention. Afr J Tradit Complement Altern Med. 2013;10(5):210–29.
pubmed: 24311829
pmcid: 3847409
Chaughule RS, Barve RS. Role of herbal medicines in the treatment of infectious diseases. Vegetos. 2023.
Kavitha N, et al. In vitro anti-Toxoplasma gondii activity of root extract/fractions of Eurycoma Longifolia Jack. BMC Complement Altern Med. 2012;12:91.
pubmed: 22781137
pmcid: 3488307
doi: 10.1186/1472-6882-12-91
Choi W, Jiang M, Chu J. Antiparasitic effects of Zingiber officinale (ginger) extract against Toxoplasma gondii. J Appl Biomed. 2013;11(1):15–26.
doi: 10.2478/v10136-012-0014-y
Ansari SH, Islam F, Sameem M. Influence of nanotechnology on herbal drugs: a review. J Adv Pharm Technol Res. 2012;3(3):142–6.
pubmed: 23057000
pmcid: 3459443
doi: 10.4103/2231-4040.101006
Cheraghipour K, et al. Encapsulation of Nepeta cataria essential oils in a chitosan nanocomposite with lethality potential against Toxoplasma gondii. Emerg Mater. 2022;5(3):653–663.
doi: 10.1007/s42247-022-00381-z
Dewi MK et al. Improved activity of herbal medicines through nanotechnology. Nanomaterials (Basel). 2022; 12(22).
Alshawwa SZ et al. Nanocarrier drug delivery systems: characterization, limitations, future perspectives and implementation of artificial intelligence. Pharmaceutics. 2022; 14(4).
Nicolas J, et al. Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. Chem Soc Rev. 2013;42(3):1147–235.
pubmed: 23238558
doi: 10.1039/C2CS35265F
Guimarães D, Cavaco-Paulo A, Nogueira E. Design of liposomes as drug delivery system for therapeutic applications. Int J Pharm. 2021;601:120571.
pubmed: 33812967
doi: 10.1016/j.ijpharm.2021.120571
Kheradmandnia S, et al. Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax. Nanomedicine. 2010;6(6):753–9.
pubmed: 20599527
doi: 10.1016/j.nano.2010.06.003
Nemati S et al. Toward waterborne protozoa detection using sensing technologies. Front Microbio. 2023; 14.
Guzman JD. Natural cinnamic acids, synthetic derivatives and hybrids with antimicrobial activity. Molecules. 2014;19(12):19292–19349.
pubmed: 25429559
pmcid: 6271800
doi: 10.3390/molecules191219292
Wiesner J, et al. Structure–activity relationships of novel anti-malarial agents. Part 2: cinnamic acid derivatives. Bioorg Med Chem Lett. 2001;11(3):423–424.
pubmed: 11212126
doi: 10.1016/S0960-894X(00)00684-3
Carvalho SA, et al. Design and synthesis of new (E)-cinnamic N-acylhydrazones as potent antitrypanosomal agents. Europ J Med Case Rep. 2012;54:512–521.
Silveira GR et al. In Vitro Anti-Toxoplasma gondii and antimicrobial activity of amides derived from cinnamic acid. Molecules. 2018;23.